Search Tag: skin clearance

Pharmacy Management

2014 26 Nov

Amgen and AstraZeneca have announced positive results from third and final pivotal phase 3 study of Brodalumab in patients with moderate-to-severe plaque psoriasis. AMAGINE-2, a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1800 patients with moderate to severe plaque psoriasis has successfully met its primary...Read more